Log in

NASDAQ:IOSP - Innospec Stock Price, Forecast & News

$99.82
-0.82 (-0.81 %)
(As of 12/16/2019 06:12 AM ET)
Today's Range
$99.30
Now: $99.82
$101.27
50-Day Range
$90.02
MA: $96.37
$101.92
52-Week Range
$53.07
Now: $99.82
$107.10
Volume78,743 shs
Average Volume83,076 shs
Market Capitalization$2.45 billion
P/E Ratio18.52
Dividend Yield1.04%
Beta1.27
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.48 billion
Cash Flow$6.90 per share
Book Value$33.80 per share

Profitability

Net Income$85 million

Miscellaneous

Employees2,000
Market Cap$2.45 billion
Next Earnings Date2/18/2020 (Estimated)
OptionableOptionable

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.


Innospec (NASDAQ:IOSP) Frequently Asked Questions

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, November 5th. Shareholders of record on Tuesday, November 19th will be paid a dividend of $0.52 per share on Wednesday, November 27th. The ex-dividend date is Monday, November 18th. This is an increase from Innospec's previous Semi-Annual dividend of $0.50. View Innospec's Dividend History.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) posted its quarterly earnings results on Tuesday, November, 5th. The specialty chemicals company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.25 by $0.15. The specialty chemicals company earned $371.90 million during the quarter, compared to analysts' expectations of $367.65 million. Innospec had a return on equity of 15.52% and a net margin of 6.69%. The firm's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period last year, the company earned $1.20 earnings per share. View Innospec's Earnings History.

When is Innospec's next earnings date?

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for Innospec.

What price target have analysts set for IOSP?

1 brokerages have issued twelve-month target prices for Innospec's stock. Their forecasts range from $95.00 to $95.00. On average, they anticipate Innospec's stock price to reach $95.00 in the next twelve months. This suggests that the stock has a possible downside of 4.8%. View Analyst Price Targets for Innospec.

What is the consensus analysts' recommendation for Innospec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.

Has Innospec been receiving favorable news coverage?

Media coverage about IOSP stock has trended negative on Monday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Innospec earned a news impact score of -2.8 on InfoTrie's scale. They also assigned media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Innospec.

Are investors shorting Innospec?

Innospec saw a decline in short interest in the month of November. As of November 29th, there was short interest totalling 268,200 shares, a decline of 12.1% from the November 14th total of 305,000 shares. Based on an average trading volume of 105,300 shares, the days-to-cover ratio is presently 2.5 days. Approximately 1.1% of the shares of the company are short sold. View Innospec's Current Options Chain.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Who are Innospec's key executives?

Innospec's management team includes the folowing people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 54)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 53)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 60)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 70)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 60)

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (2.90%), Eagle Asset Management Inc. (0.95%), Kirr Marbach & Co. LLC IN (0.71%), Rhumbline Advisers (0.31%), Millennium Management LLC (0.29%) and California Public Employees Retirement System (0.23%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, State Street Corp, Eagle Asset Management Inc., First Quadrant L P CA, ZWJ Investment Counsel Inc., Creative Planning, Municipal Employees Retirement System of Michigan and CNA Financial Corp. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

Which institutional investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Man Group plc, California Public Employees Retirement System, Squarepoint Ops LLC, SG Americas Securities LLC, Russell Investments Group Ltd., State of Alaska Department of Revenue, Chicago Equity Partners LLC and Voloridge Investment Management LLC. View Insider Buying and Selling for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $99.82.

How big of a company is Innospec?

Innospec has a market capitalization of $2.45 billion and generates $1.48 billion in revenue each year. Innospec employs 2,000 workers across the globe.View Additional Information About Innospec.

What is Innospec's official website?

The official website for Innospec is http://www.innospecinc.com/.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


MarketBeat Community Rating for Innospec (NASDAQ IOSP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  245 (Vote Outperform)
Underperform Votes:  241 (Vote Underperform)
Total Votes:  486
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Featured Article: What is net income?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel